Doylestown, PA, United States of America

Darryl Roberts

This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignees: Elutia Inc., Elutia Med LLC. Active years: 2025-2026.

USPTO Granted Patents = 2 

% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2025-2026

Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovations of Darryl Roberts

Introduction

Darryl Roberts is an accomplished inventor based in Doylestown, PA. He has made significant contributions to the field of regenerative medicine through his innovative work with placental tissue. His research focuses on the potential benefits of using preterm placental tissue for tissue regeneration and healing.

Latest Patents

Darryl holds a patent for "Placental tissue compositions and methods." This patent discloses methods and compositions of decellularized preterm placental tissue. The compositions comprise decellularized regenerative tissue derived from animal placentas that are harvested preterm, before the completion of the normal duration of gestation. Preterm placental tissue may contain a high level of growth factors and other beneficial components that aid in tissue regeneration and healing.

Career Highlights

Darryl Roberts has dedicated his career to advancing the understanding and application of placental tissue in medical treatments. His work has the potential to revolutionize how regenerative medicine approaches healing and tissue repair.

Collaborations

Darryl collaborates with talented individuals such as Ji Zhang and Daniel Deegan, who contribute to the innovative environment at Elutia Inc.

Conclusion

Darryl Roberts is a pioneering inventor whose work with placental tissue compositions is paving the way for advancements in regenerative medicine. His contributions are significant and hold promise for future medical applications.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…